Literature DB >> 25010779

Interrelatedness between C-reactive protein and oxidized low-density lipoprotein.

Milan M Obradovic, Andreja Trpkovic, Vladan Bajic, Sanja Soskic, Aleksandra Jovanovic, Julijana Stanimirovic, Milos Panic, Esma R Isenovic.   

Abstract

C-reactive protein (CRP) is a marker of inflammation. Atherosclerosis is now recognized as inflammatory disease, and it seems that CRP directly contributes to atherogenesis. Oxidation of low-density lipoprotein (LDL) molecule increases the uptake of lipid products by macrophages leading to cholesterol accumulation and subsequent foam cell formation. The elevated levels of high sensitivity CRP (hsCRP) and oxidized LDL (OxLDL) in the blood were found to be associated with cardiovascular diseases (CVD). In this review, we highlighted the evidence that CRP and OxLDL are involved in interrelated (patho) physiological pathways. The findings on association between hsCRP and OxLDL in the clinical setting will be also summarized.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25010779     DOI: 10.1515/cclm-2014-0590

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

Review 1.  The Health Consequences of Obesity in Young Adulthood.

Authors:  Hoi Lun Cheng; Sharon Medlow; Katharine Steinbeck
Journal:  Curr Obes Rep       Date:  2016-03

Review 2.  Role of C-Reactive Protein in Diabetic Inflammation.

Authors:  Julijana Stanimirovic; Jelena Radovanovic; Katarina Banjac; Milan Obradovic; Magbubah Essack; Sonja Zafirovic; Zoran Gluvic; Takashi Gojobori; Esma R Isenovic
Journal:  Mediators Inflamm       Date:  2022-05-17       Impact factor: 4.529

3.  Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells.

Authors:  Lei Tian; Kan Chen; Jiatian Cao; Zhihua Han; Lin Gao; Yue Wang; Yuqi Fan; Changqian Wang
Journal:  Mol Med Rep       Date:  2015-07-13       Impact factor: 2.952

4.  M2 Monocyte Polarization in Dialyzed Patients Is Associated with Increased Levels of M-CSF and Myeloperoxidase-Associated Oxidative Stress: Preliminary Results.

Authors:  Valérie Pireaux; Cédric Delporte; Alexandre Rousseau; Jean-Marc Desmet; Pierre Van Antwerpen; Martine Raes; Karim Zouaoui Boudjeltia
Journal:  Biomedicines       Date:  2021-01-16

5.  Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome.

Authors:  Shoh Sasaki; Kensaku Nishihira; Atsushi Yamashita; Tomomi Fujii; Kenji Onoue; Yoshihiko Saito; Kinta Hatakeyama; Yoshisato Shibata; Yujiro Asada; Chiho Ohbayashi
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

Review 6.  The Effect of Blood Pressure Variability on Coronary Atherosclerosis Plaques.

Authors:  Yue Liu; Xing Luo; Haibo Jia; Bo Yu
Journal:  Front Cardiovasc Med       Date:  2022-03-15

Review 7.  The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis.

Authors:  Tannaz Jamialahmadi; Fatemeh Baratzadeh; Željko Reiner; Massimo R Mannarino; Vladimiro Cardenia; Luis E Simental-Mendía; Matteo Pirro; Gerald F Watts; Amirhossein Sahebkar
Journal:  Oxid Med Cell Longev       Date:  2022-08-01       Impact factor: 7.310

8.  The relationship between oxidized low-density lipoprotein and related ratio and acute cerebral infarction.

Authors:  Zhen Yan; Baosheng Fu; Dan He; Yudi Zhang; Juanjuan Liu; Xiangjian Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

9.  Plasma Retinol Levels and High-Sensitivity C-Reactive Protein in Prepubertal Children.

Authors:  Olaya de Dios; Pilar Navarro; Henar Ortega-Senovilla; Leticia Herrero; Teresa Gavela-Pérez; Leandro Soriano-Guillen; Miguel A Lasunción; Carmen Garcés
Journal:  Nutrients       Date:  2018-09-07       Impact factor: 5.717

Review 10.  Functionality of C-Reactive Protein for Atheroprotection.

Authors:  Sanjay K Singh; Alok Agrawal
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.